Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
475.91
-2.67 (-0.56%)
At close: Oct 28, 2025, 4:00 PM EDT
476.02
+0.11 (0.02%)
After-hours: Oct 28, 2025, 6:45 PM EDT

Alnylam Pharmaceuticals Employees

Alnylam Pharmaceuticals had 2,230 employees as of December 31, 2024. The number of employees increased by 130 or 6.19% compared to the previous year.

Employees
2,230
Change (1Y)
130
Growth (1Y)
6.19%
Revenue / Employee
$1,104,019
Profits / Employee
-$143,089
Market Cap
62.38B

Employees Chart

Employees History

DateEmployeesChangeGrowth
Dec 31, 20242,2301306.19%
Dec 31, 20232,100984.90%
Dec 31, 20222,00233720.24%
Dec 31, 20211,66521214.59%
Dec 31, 20201,4531309.83%
Dec 31, 20191,32325824.23%
Dec 31, 20181,06531642.19%
Dec 31, 201774923545.72%
Dec 31, 201651414539.30%
Dec 31, 201536911344.14%
Dec 31, 20142569155.15%
Dec 31, 20131653627.91%
Dec 31, 20121291311.21%
Dec 31, 2011116-56-32.56%
Dec 31, 2010172-6-3.37%
Dec 31, 200917884.71%
Dec 31, 20081704131.78%
Dec 31, 200712975.74%
Dec 31, 20061222829.79%
Dec 31, 2005942332.39%
Dec 31, 2004711118.33%
Dec 31, 200360--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.